Eifelhöhen-Klinik AG
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eife… Read more
Eifelhöhen-Klinik AG (EIF) - Net Assets
Latest net assets as of December 2024: €12.61 Million EUR
Based on the latest financial reports, Eifelhöhen-Klinik AG (EIF) has net assets worth €12.61 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€36.20 Million) and total liabilities (€23.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €12.61 Million |
| % of Total Assets | 34.83% |
| Annual Growth Rate | -2.67% |
| 5-Year Change | -15.54% |
| 10-Year Change | -14.17% |
| Growth Volatility | 15.68 |
Eifelhöhen-Klinik AG - Net Assets Trend (2013–2024)
This chart illustrates how Eifelhöhen-Klinik AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Eifelhöhen-Klinik AG (2013–2024)
The table below shows the annual net assets of Eifelhöhen-Klinik AG from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €12.61 Million | -0.79% |
| 2023-12-31 | €12.71 Million | +28.68% |
| 2022-12-31 | €9.88 Million | -8.58% |
| 2021-12-31 | €10.81 Million | -27.63% |
| 2020-12-31 | €14.93 Million | -10.34% |
| 2019-12-31 | €16.65 Million | +2.17% |
| 2018-12-31 | €16.30 Million | -7.94% |
| 2017-12-31 | €17.70 Million | -5.10% |
| 2016-12-31 | €18.66 Million | +26.98% |
| 2015-12-31 | €14.69 Million | -2.03% |
| 2014-12-31 | €15.00 Million | -11.68% |
| 2013-12-31 | €16.98 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eifelhöhen-Klinik AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 85.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.05 Million | 9.04% |
| Other Components | €10.54 Million | 90.96% |
| Total Equity | €11.59 Million | 100.00% |
Eifelhöhen-Klinik AG Competitors by Market Cap
The table below lists competitors of Eifelhöhen-Klinik AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kedawung Setia Industrial Tbk
JK:KDSI
|
$4.38 Million |
|
Pilatus Marine PCL
BK:PLT
|
$4.38 Million |
|
BPH Energy Ltd
AU:BPH
|
$4.38 Million |
|
Auplata SA
PA:ALAMG
|
$4.39 Million |
|
Bong AB (publ)
ST:BONG
|
$4.38 Million |
|
ALDUX
PA:ALDUX
|
$4.38 Million |
|
Petrolia SE
OL:PSE
|
$4.38 Million |
|
Meritage Hospitality Group Inc
OTCQX:MHGU
|
$4.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eifelhöhen-Klinik AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 11,800,067 to 11,590,592, a change of -209,475 (-1.8%).
- Net income of 84,379 contributed positively to equity growth.
- Share repurchases of 314,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €84.38K | +0.73% |
| Share Repurchases | €314.00K | -2.71% |
| Other Changes | €20.15K | +0.17% |
| Total Change | €- | -1.78% |
Book Value vs Market Value Analysis
This analysis compares Eifelhöhen-Klinik AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.78x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.56x to 0.78x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €5.71 | €3.20 | x |
| 2018-12-31 | €5.22 | €3.20 | x |
| 2019-12-31 | €5.30 | €3.20 | x |
| 2020-12-31 | €4.75 | €3.20 | x |
| 2021-12-31 | €3.32 | €3.20 | x |
| 2022-12-31 | €3.05 | €3.20 | x |
| 2023-12-31 | €3.91 | €3.20 | x |
| 2024-12-31 | €4.13 | €3.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eifelhöhen-Klinik AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.17%
- • Asset Turnover: 1.35x
- • Equity Multiplier: 3.12x
- Recent ROE (0.73%) is above the historical average (-5.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -0.94% | -0.39% | 0.83x | 2.85x | €-1.83 Million |
| 2014 | 0.23% | 0.08% | 0.66x | 4.43x | €-1.44 Million |
| 2015 | -6.71% | -2.05% | 0.70x | 4.68x | €-2.41 Million |
| 2016 | 24.78% | 9.44% | 0.83x | 3.17x | €2.69 Million |
| 2017 | -0.66% | -0.24% | 0.77x | 3.52x | €-1.84 Million |
| 2018 | -7.06% | -2.25% | 0.88x | 3.55x | €-2.69 Million |
| 2019 | -4.83% | -1.60% | 0.63x | 4.77x | €-2.37 Million |
| 2020 | -9.90% | -4.00% | 0.50x | 4.91x | €-2.85 Million |
| 2021 | -43.93% | -12.29% | 0.45x | 7.92x | €-5.40 Million |
| 2022 | -20.52% | -5.03% | 0.50x | 8.20x | €-2.81 Million |
| 2023 | 4.08% | 1.06% | 1.20x | 3.21x | €-698.70K |
| 2024 | 0.73% | 0.17% | 1.35x | 3.12x | €-1.07 Million |
Industry Comparison
This section compares Eifelhöhen-Klinik AG's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,711,847,000
- Average return on equity (ROE) among peers: 6.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eifelhöhen-Klinik AG (EIF) | €12.61 Million | -0.94% | 1.87x | $4.38 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |